Donoghue Forlines Dividend Fund I (PWDIX)
8.94
+0.14
(+1.59%)
USD |
Apr 24 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 2.01% | 63.30M | 3.36% | 193.0% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 38.18M | 3.49% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide total return from income and secondarily, capital appreciation. The Fund invests primarily in equally-weighted stocks at the beginning of each quarter that produced the highest dividend yields from each of the ten industry sectors that comprise the S&P 500 Index on an annual basis. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Income |
| Peer Group | Equity Income Funds |
| Global Macro | Equity North America |
| US Macro | Equity Income Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Equity Income Funds |
| Fund Owner Firm Name | Donoghue Forlines Funds |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
37
-895.79M
Peer Group Low
1.238B
Peer Group High
1 Year
% Rank:
14
38.18M
-7.373B
Peer Group Low
9.730B
Peer Group High
3 Months
% Rank:
39
-2.408B
Peer Group Low
3.062B
Peer Group High
3 Years
% Rank:
21
-15.01B
Peer Group Low
26.11B
Peer Group High
6 Months
% Rank:
16
-4.411B
Peer Group Low
8.541B
Peer Group High
5 Years
% Rank:
37
-15.10B
Peer Group Low
40.99B
Peer Group High
YTD
% Rank:
39
-2.408B
Peer Group Low
3.062B
Peer Group High
10 Years
% Rank:
46
-27.51B
Peer Group Low
46.73B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of April 25, 2025.
Asset Allocation
As of January 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.77% |
| Stock | 98.02% |
| Bond | 1.21% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| CVS Health Corp | 2.44% | 65.33 | -0.90% |
| Gilead Sciences Inc | 2.38% | 103.13 | -2.85% |
| Philip Morris International Inc | 2.36% | 170.20 | 0.08% |
| AbbVie Inc | 2.31% | 186.11 | 3.18% |
| AT&T Inc | 2.25% | 26.77 | -2.76% |
| Amgen Inc | 2.17% | 280.75 | 0.33% |
| Bank of New York Mellon Corp | 2.15% | 78.66 | -0.08% |
| Citigroup Inc | 2.14% | 68.43 | 0.40% |
| Medtronic PLC | 2.14% | 84.17 | -0.15% |
| NRG Energy Inc | 2.13% | 108.28 | 2.05% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.99% |
| Administration Fee | 22.57K% |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | 0.00% |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 10000.00 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide total return from income and secondarily, capital appreciation. The Fund invests primarily in equally-weighted stocks at the beginning of each quarter that produced the highest dividend yields from each of the ten industry sectors that comprise the S&P 500 Index on an annual basis. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Income |
| Peer Group | Equity Income Funds |
| Global Macro | Equity North America |
| US Macro | Equity Income Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Equity Income Funds |
| Fund Owner Firm Name | Donoghue Forlines Funds |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (4-24-25) | 2.04% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 22.05 |
| Weighted Average Price to Sales Ratio | 3.121 |
| Weighted Average Price to Book Ratio | 5.780 |
| Weighted Median ROE | 18.27% |
| Weighted Median ROA | 4.87% |
| ROI (TTM) | 12.09% |
| Return on Investment (TTM) | 12.09% |
| Earning Yield | 0.0574 |
| LT Debt / Shareholders Equity | 1.415 |
As of January 31, 2025
Growth Metrics
| EPS Growth (1Y) | 15.63% |
| EPS Growth (3Y) | 10.35% |
| EPS Growth (5Y) | 4.75% |
| Sales Growth (1Y) | 1.12% |
| Sales Growth (3Y) | 8.88% |
| Sales Growth (5Y) | 6.19% |
| Sales per Share Growth (1Y) | 2.31% |
| Sales per Share Growth (3Y) | 9.74% |
| Operating Cash Flow - Growth Ratge (3Y) | 5.25% |
As of January 31, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:PWDIX", "name") |
| Broad Asset Class: =YCI("M:PWDIX", "broad_asset_class") |
| Broad Category: =YCI("M:PWDIX", "broad_category_group") |
| Prospectus Objective: =YCI("M:PWDIX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |